Zobrazeno 1 - 10
of 155
pro vyhledávání: '"Prostacyclin analogues"'
Autor:
Aleksander Siniarski, Aleksandra Gąsecka, Miłosz Starczyński, Marta Banaszkiewicz, Szymon Darocha, Adam Torbicki, Marcin Kurzyna, Krzysztof J. Filipiak, Jadwiga Nessler, Grzegorz Gajos
Publikováno v:
Platelets, Vol 33, Iss 7, Pp 1065-1074 (2022)
Prostacyclin (PGI2) analogues (epoprostenol, treprostonil, iloprost) are the cornerstone of pulmonary arterial hypertension (PAH) treatment. PGI2 analogues inhibit platelet reactivity, but their impact on coagulation and fibrinolysis parameters has n
Externí odkaz:
https://doaj.org/article/498839e26d14420ca05eb999e0e58e16
Autor:
Nazzareno Galiè, Marc Humbert, Jean-Luc Vachiery, Simon Gibbs, Irene Lang, Adam Torbicki, Gérald Simonneau, Andrew Peacock, Anton Vonk Noordegraaf, Maurice Beghetti, Ardeschir Ghofrani, Miguel Angel Gomez Sanchez, Georg Hansmann, Walter Klepetko, Patrizio Lancellotti, Marco Matucci, Theresa McDonagh, Luc A. Pierard, Pedro T. Trindade, Maurizio Zompatori, Marius Hoeper
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 5, Pp 5-64 (2016)
The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), In
Externí odkaz:
https://doaj.org/article/6a64d604b4254ff4a5ceb98c50348ba5
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 7, Iss 2, Pp 199-203 (2016)
Data about chronic thromboembolic pulmonary hypertension (CTPH) prevalence is presented. The main CTPH clinical manifestations are described. The possible reasons and pathogenetic mechanisms of CTPH development are discussed. Features of unfavorable
Externí odkaz:
https://doaj.org/article/742081c33a9c4b3692950e06492be280
Publikováno v:
European Heart Journal. 43(38)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___00893::b38419e44683cbcc065880f971d34105
https://doi.org/10.1093/eurheartj/ehac237
https://doi.org/10.1093/eurheartj/ehac237
Autor:
Humbert, Marc, Kovacs, Gabor, Hoeper, Marius M., Badagliacca, Roberto, Berger, Rolf M. F., Brida, Margarita, Carlsen, Jorn, Coats, Andrew J. S., Escribano-Subias, Pilar, Ferrari, Pisana, Ferreira, Diogenes S., Ghofrani, Hossein Ardeschir, Giannakoulas, George, Kiely, David G., Mayer, Eckhard, Meszaros, Gergely, Nagavci, Blin, Olsson, Karen M., Pepke-Zaba, Joanna, Quint, Jennifer K., Radegran, Goran, Simonneau, Gerald, Sitbon, Olivier, Tonia, Thomy, Toshner, Mark, Vachiery, Jean-Luc, Noordegraaf, Anton Vonk, Delcroix, Marion, Rosenkranz, Stephan, Schwerzmann, Markus, Anh-Tuan Dinh-Xuan, Bush, Andy, Abdelhamid, Magdy, Aboyans, Victor, Arbustini, Eloisa, Asteggiano, Riccardo, Barbera, Joan-Albert, Beghetti, Maurice, Cikes, Maja, Condliffe, Robin, de Man, Frances, Falk, Volkmar, Fauchier, Laurent, Gaine, Sean, Galie, Nazzareno, Gin-Sing, Wendy, Granton, John, Grunig, Ekkehard, Hassoun, Paul M., Hellemons, Merel
Publikováno v:
European Heart Journal, 43(38). Oxford University Press
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::982277951cf35c57514e12cfba4cf62a
https://research.rug.nl/en/publications/4f09500a-c9f3-4357-8a8e-ebd2f122fc3b
https://research.rug.nl/en/publications/4f09500a-c9f3-4357-8a8e-ebd2f122fc3b
Autor:
Preston, Ioana R., Feldman, Jeremy, White, James, Franco, Veronica, Ishizawar, David, Burger, Charles, Waxman, Aaron B., Hill, Nicholas S.
Publikováno v:
Pulmonary Circulation, 2014 Sep 01. 4(3), 456-461.
Externí odkaz:
https://www.jstor.org/stable/10.1086/677360
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
European Heart Journal: Case Reports
Background There are significant risks of parenteral prostacyclin use in patients with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD), which may limit their use. Selexipag is an oral, selective prostacyclin analogu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1913e6799ba31d8bcffe3ae02f3df2e
https://doi.org/10.1093/ehjcr/ytaa320
https://doi.org/10.1093/ehjcr/ytaa320
Autor:
Kae-Woei Liang, Kuo-Yang Wang
Publikováno v:
European Heart Journal: Case Reports
Background Intravenous (IV) prostacyclin analogues infusion and balloon atrial septostomy (BAS) are two important treatment options for managing advanced right heart failure in patients with idiopathic pulmonary arterial hypertension (IPAH). Referenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e758f6f8ede6b550640536436c41afb
http://europepmc.org/articles/PMC7319844
http://europepmc.org/articles/PMC7319844
Publikováno v:
European Respiratory Review, Vol 18, Iss 114, Pp 253-259 (2009)
The present review aims to examine the effect of specific drugs on long-term outcome of pulmonary arterial hypertension (PAH), to critically review the available data, and to derive useful information for daily patient care. PAH is an intrinsic disea
Externí odkaz:
https://doaj.org/article/9a59d17d6f6e4b67a53ac47cfbaa19e8